UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 23 filers reported holding UROVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $477,000 | -5.2% | 51,100 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $503,000 | +6.8% | 51,100 | 0.0% | 0.01% | -9.1% |
| Q1 2020 | $471,000 | -40.6% | 51,100 | 0.0% | 0.01% | -21.4% |
| Q4 2019 | $793,000 | +63.8% | 51,100 | 0.0% | 0.01% | +55.6% |
| Q3 2019 | $484,000 | +19.8% | 51,100 | 0.0% | 0.01% | +28.6% |
| Q2 2019 | $404,000 | -21.4% | 51,100 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $514,000 | +52.5% | 51,100 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $337,000 | -62.6% | 51,100 | -31.9% | 0.01% | -50.0% |
| Q3 2018 | $900,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|